InfuSystem Holdings (INFU) Cash & Equivalents (2010 - 2026)
InfuSystem Holdings (INFU) posted Cash & Equivalents of $2.1 million for Q1 2026, down 33.9% on a QoQ basis from $3.2 million in Q4 2025, and up 39.84% year-over-year from $1.5 million in Q1 2025.
InfuSystem Holdings (INFU) Cash & Equivalents (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- Quarterly Cash & Equivalents rose 39.84% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 39.84% YoY) and the FY2025 annual result came in at $3.2 million, up 504.55% from the prior year.
- Cash & Equivalents was $2.1 million for Q1 2026 at InfuSystem Holdings, down from $3.2 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $3.2 million in Q4 2025 and bottomed at $134000.0 in Q2 2023.
- A 5-year average of $727882.4 and a median of $380000.0 in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 85.33% — and 2025, when it surged 504.55%.
- InfuSystem Holdings' Cash & Equivalents stood at $165000.0 in 2022, then soared by 40.0% to $231000.0 in 2023, then surged by 128.14% to $527000.0 in 2024, then jumped by 504.55% to $3.2 million in 2025, then tumbled by 33.9% to $2.1 million in 2026.
- Business Quant data shows INFU's Cash & Equivalents at $2.1 million in Q1 2026, $3.2 million in Q4 2025, and $955000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 3.19 Mn |
| Sep 30, 2025 | 955,000.00 |
| Jun 30, 2025 | 720,000.00 |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 527,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Mar 31, 2024 | 822,000.00 |
| Dec 31, 2023 | 231,000.00 |
| Sep 30, 2023 | 161,000.00 |
| Jun 30, 2023 | 134,000.00 |
| Mar 31, 2023 | 256,000.00 |
| Dec 31, 2022 | 165,000.00 |
| Sep 30, 2022 | 363,000.00 |
| Jun 30, 2022 | 311,000.00 |
| Mar 31, 2022 | 405,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 165,000.00 |
| Jun 30, 2021 | 164,000.00 |